Exploring the effect of training community pharmacy staff in mentalization-based communication on recognizing patients' drug related problems: an uncontrolled pre-post intervention study in Denmark and the Netherlands
Ellen van Loon, Stijn Crutzen, Ramune Jacobsen, Ulla Hedegaard, Marcia Vervloet, Laura Schackmann, Liset van Dijk, Susanne Kaae, Katja Taxis

TL;DR
This study explores how training pharmacy staff in mentalization-based communication affects their ability to identify drug-related problems during patient interactions.
Contribution
The study introduces a mentalizing education program for pharmacy staff and evaluates its impact on recognizing drug-related problems in real-world settings.
Findings
The overall increase in recognized drug-related problems was not statistically significant, but a significant increase was observed in the Netherlands.
Categories like 'compliance' and 'monitoring' increased, while 'drug selection' and 'over/under dose' decreased.
Referrals to other healthcare providers dropped significantly in Denmark after the intervention.
Abstract
To explore the effect of a comprehensive mentalizing education programme on pharmacy staff's ability to recognize drug related problems (DRPs) during counter conversations in community pharmacies. A multicentre, uncontrolled pre-post-intervention study was conducted in Danish and Dutch pharmacies. Over four months, pharmacists and pharmacy technicians completed a parttime mentalizing education programme. Participants documented all DRPs they recognized during six hours of counter conversations before and after the intervention. Data were analysed using mixed multilevel logistic regression, including a post-hoc comparison between countries. Forty-one participants from twenty pharmacies registered 2507 conversations. The overall increase of recognized DRP frequency from 17.5% to 22.1% was not significant (p = 0.086). Post-hoc analysis showed a significant increase in the Netherlands…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSchizophrenia research and treatment · Mental Health Treatment and Access · Pharmaceutical Practices and Patient Outcomes
